On Thursday, Morgan Stanley (NYSE:MS) raised its rating on Equifax (NYSE: EFX) from Equalweight to Overweight, simultaneously increasing the price target to $320 from the previous $275. The firm's analyst highlighted anticipated improvements in consumer credit conditions and a more favorable regulatory environment as key factors behind the upgrade.
Additionally, the potential for significant mortgage upside was cited as a driver for the company's expected outperformance. Currently trading at $262.74, the stock sits within a broader analyst target range of $272-$380, though InvestingPro analysis suggests the stock is trading above its Fair Value.
The analyst projects that revenue growth for Bureaus, which includes Equifax, will accelerate in 2025, signaling the start of a multi-year upcycle trend. Revenue is forecasted to grow in the low-to-mid-teens, with the possibility of doubling earnings per share (EPS) by 2027. This optimistic outlook follows a period of subdued credit cycle from 2022 to 2024.
InvestingPro data shows the company maintaining impressive gross profit margins of 55.53%, though 7 analysts have recently revised their earnings expectations downward. Subscribers can access 12 additional ProTips and comprehensive valuation metrics.
The recovery in consumer credit and mortgage upside, although still uncertain in timing, are posited to benefit from near-term interest rate cuts. These cuts are seen as positive catalysts that could bolster Equifax's performance. With a beta of 1.57, investors should note the stock's higher volatility compared to the market. The analyst expressed confidence in Equifax's prospects, suggesting that the potential rewards justify the stock's current valuation, even considering the need for some patience from investors due to the timing of the anticipated upside.
In their comments, the analyst from Morgan Stanley stated, "We believe it is better to be early for EFX, especially as bear case in '25 still presents an attractive opportunity." This suggests a belief that even under less favorable conditions, Equifax's position in 2025 would still offer a worthwhile investment opportunity. The upgrade reflects a long-term positive view on the stock, with expectations of a significant upturn in the years ahead.
In other recent news, Equifax Inc (NYSE:EFX). reported strong Q3 performance, with revenues reaching $1.42 billion, a 9% increase year-over-year. The company also raised its full-year guidance and highlighted progress in its cloud transformation efforts, with 80% of the revenue now in the Equifax Cloud. Equifax is projecting Q4 revenue between $1.438 billion and $1.458 billion and anticipates around 10% constant currency revenue growth for the full year 2024.
Equifax's CEO, Mark W. Begor, has extended his tenure beyond 2025, a move that promises continuity in the company's strategic direction. Under his leadership, Equifax has seen its market capitalization grow significantly and has invested heavily in technology and strategic acquisitions.
However, Oppenheimer has adjusted its stock price target for Equifax, reducing it to $286.00 from the previous target of $315.00, while retaining its Outperform rating. The firm cites new developments including the outcome of the recent presidential election, management's remarks at an industry conference, and fresh industry data from October as reasons for the revision.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.